

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.66591575 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.66591575 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.66591575 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.66591575 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.66591575 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.66591575 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.67598771 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.35337932 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.23479063 |
| 10 | microglial cell activation (GO:0001774) | 4.02347926 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99655548 |
| 12 | neuronal action potential propagation (GO:0019227) | 3.94789558 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93249808 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86093475 |
| 15 | response to host immune response (GO:0052572) | 3.86093475 |
| 16 | gamma-aminobutyric acid transport (GO:0015812) | 3.82092562 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.77984222 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.61136013 |
| 19 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.47986015 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.47411942 |
| 21 | response to host (GO:0075136) | 3.47411942 |
| 22 | response to host defenses (GO:0052200) | 3.47411942 |
| 23 | response to peptidoglycan (GO:0032494) | 3.33400862 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.31160765 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.31160765 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30406478 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13885659 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12108189 |
| 29 | macrophage activation (GO:0042116) | 3.11749229 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 3.10712641 |
| 31 | I-kappaB phosphorylation (GO:0007252) | 3.06300218 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05935811 |
| 33 | glutamate secretion (GO:0014047) | 3.04993569 |
| 34 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01752680 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.00365086 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00223436 |
| 37 | germinal center formation (GO:0002467) | 2.98607380 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.97852951 |
| 39 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.97294429 |
| 40 | natural killer cell mediated immunity (GO:0002228) | 2.97294429 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 2.96715905 |
| 42 | postsynaptic membrane organization (GO:0001941) | 2.95839344 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 2.93102502 |
| 44 | serotonin metabolic process (GO:0042428) | 2.92625585 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 2.90193172 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 2.89938841 |
| 47 | L-amino acid import (GO:0043092) | 2.89297770 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.86680902 |
| 49 | respiratory burst (GO:0045730) | 2.85331679 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 2.84253507 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 2.83879911 |
| 52 | response to muramyl dipeptide (GO:0032495) | 2.82864392 |
| 53 | proline transport (GO:0015824) | 2.82803157 |
| 54 | neutrophil activation (GO:0042119) | 2.80588471 |
| 55 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.76975303 |
| 56 | granulocyte activation (GO:0036230) | 2.76739790 |
| 57 | presynaptic membrane assembly (GO:0097105) | 2.76397539 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76264381 |
| 59 | neuron-neuron synaptic transmission (GO:0007270) | 2.76101044 |
| 60 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72680985 |
| 61 | presynaptic membrane organization (GO:0097090) | 2.71727659 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.71653302 |
| 63 | vocalization behavior (GO:0071625) | 2.70153015 |
| 64 | regulation of platelet aggregation (GO:0090330) | 2.69649166 |
| 65 | cellular response to ethanol (GO:0071361) | 2.69267458 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67994118 |
| 67 | positive regulation of mast cell degranulation (GO:0043306) | 2.67994118 |
| 68 | neutrophil mediated immunity (GO:0002446) | 2.67244663 |
| 69 | neurotransmitter secretion (GO:0007269) | 2.66493587 |
| 70 | primary amino compound metabolic process (GO:1901160) | 2.66392170 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65981984 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65209757 |
| 73 | regulation of mast cell activation (GO:0033003) | 2.59298690 |
| 74 | potassium ion import (GO:0010107) | 2.59167773 |
| 75 | adult walking behavior (GO:0007628) | 2.58846193 |
| 76 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.57799132 |
| 77 | neuronal action potential (GO:0019228) | 2.56860112 |
| 78 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56623100 |
| 79 | behavioral response to nicotine (GO:0035095) | 2.55490502 |
| 80 | synaptic vesicle maturation (GO:0016188) | 2.55338822 |
| 81 | transmission of nerve impulse (GO:0019226) | 2.55187823 |
| 82 | fucose catabolic process (GO:0019317) | 2.54938932 |
| 83 | L-fucose metabolic process (GO:0042354) | 2.54938932 |
| 84 | L-fucose catabolic process (GO:0042355) | 2.54938932 |
| 85 | G-protein coupled receptor internalization (GO:0002031) | 2.53486624 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 2.52630649 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.51555307 |
| 88 | neuromuscular synaptic transmission (GO:0007274) | 2.50852535 |
| 89 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.50672722 |
| 90 | establishment of protein localization to Golgi (GO:0072600) | 2.50558428 |
| 91 | startle response (GO:0001964) | 2.50545012 |
| 92 | phagosome maturation (GO:0090382) | 2.48720647 |
| 93 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.48212590 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.48172605 |
| 95 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47914718 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.47769926 |
| 97 | cyclic nucleotide catabolic process (GO:0009214) | 2.47657860 |
| 98 | neuronal ion channel clustering (GO:0045161) | 2.47221618 |
| 99 | locomotory exploration behavior (GO:0035641) | 2.46894976 |
| 100 | regulation of neurotransmitter secretion (GO:0046928) | 2.46013664 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.45210604 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.45110354 |
| 103 | negative regulation of mast cell activation (GO:0033004) | 2.44913822 |
| 104 | synaptic vesicle endocytosis (GO:0048488) | 2.44244015 |
| 105 | regulation of ARF protein signal transduction (GO:0032012) | 2.43905376 |
| 106 | exploration behavior (GO:0035640) | 2.43758523 |
| 107 | regulation of regulated secretory pathway (GO:1903305) | 2.43719128 |
| 108 | nerve growth factor signaling pathway (GO:0038180) | 2.42656599 |
| 109 | T cell mediated immunity (GO:0002456) | 2.42485970 |
| 110 | central nervous system myelination (GO:0022010) | 2.42186110 |
| 111 | axon ensheathment in central nervous system (GO:0032291) | 2.42186110 |
| 112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.42014280 |
| 113 | cAMP catabolic process (GO:0006198) | 2.41761965 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40438091 |
| 115 | protein localization to synapse (GO:0035418) | 2.40437361 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.40117993 |
| 117 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.39489531 |
| 118 | positive regulation of heat generation (GO:0031652) | 2.39223685 |
| 119 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.39024187 |
| 120 | detection of light stimulus involved in visual perception (GO:0050908) | 2.39024187 |
| 121 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.38304003 |
| 122 | positive regulation of macrophage cytokine production (GO:0060907) | 2.36936164 |
| 123 | mature B cell differentiation (GO:0002335) | 2.36790972 |
| 124 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36500482 |
| 125 | dendritic spine morphogenesis (GO:0060997) | 2.36211612 |
| 126 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.35431939 |
| 127 | negative regulation of dendrite development (GO:2000171) | 2.34998676 |
| 128 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.34885787 |
| 129 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.34600719 |
| 130 | defense response to protozoan (GO:0042832) | 2.34589114 |
| 131 | membrane depolarization (GO:0051899) | 2.34527489 |
| 132 | positive regulation of interleukin-12 production (GO:0032735) | 2.34426759 |
| 133 | activated T cell proliferation (GO:0050798) | 2.33958292 |
| 134 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.33830212 |
| 135 | negative regulation of neurotransmitter transport (GO:0051589) | 2.33330815 |
| 136 | regulation of postsynaptic membrane potential (GO:0060078) | 2.32996752 |
| 137 | auditory behavior (GO:0031223) | 2.32529744 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.31348101 |
| 139 | phosphorelay signal transduction system (GO:0000160) | 2.31224045 |
| 140 | positive regulation of interferon-beta production (GO:0032728) | 2.31056891 |
| 141 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.30903615 |
| 142 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.27890254 |
| 143 | B cell homeostasis (GO:0001782) | 2.27384393 |
| 144 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.26653960 |
| 145 | neurotransmitter transport (GO:0006836) | 2.26118038 |
| 146 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.26015331 |
| 147 | regulation of synaptic vesicle transport (GO:1902803) | 2.25914804 |
| 148 | cellular potassium ion homeostasis (GO:0030007) | 2.25797276 |
| 149 | synaptic vesicle exocytosis (GO:0016079) | 2.25607144 |
| 150 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.25536772 |
| 151 | negative regulation of interleukin-17 production (GO:0032700) | 2.25223037 |
| 152 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.24494565 |
| 153 | regulation of sarcomere organization (GO:0060297) | 2.24217461 |
| 154 | regulation of dendritic spine development (GO:0060998) | 2.23393028 |
| 155 | vesicle transport along microtubule (GO:0047496) | 2.23299806 |
| 156 | indole-containing compound metabolic process (GO:0042430) | 2.23176906 |
| 157 | amino acid import (GO:0043090) | 2.22686459 |
| 158 | intracellular pH reduction (GO:0051452) | 2.22094005 |
| 159 | potassium ion transmembrane transport (GO:0071805) | 2.21598754 |
| 160 | cellular potassium ion transport (GO:0071804) | 2.21598754 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.21394640 |
| 162 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.21110312 |
| 163 | myeloid leukocyte activation (GO:0002274) | 2.20713241 |
| 164 | regulation of germinal center formation (GO:0002634) | 2.19382538 |
| 165 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.19089642 |
| 166 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.19009110 |
| 167 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.18998406 |
| 168 | protein K11-linked deubiquitination (GO:0035871) | 2.18316575 |
| 169 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.17976487 |
| 170 | glycosphingolipid biosynthetic process (GO:0006688) | 2.17122430 |
| 171 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.16612346 |
| 172 | central nervous system neuron axonogenesis (GO:0021955) | 2.16149424 |
| 173 | regulation of neurotransmitter levels (GO:0001505) | 2.15792486 |
| 174 | behavioral defense response (GO:0002209) | 2.15300067 |
| 175 | behavioral fear response (GO:0001662) | 2.15300067 |
| 176 | interkinetic nuclear migration (GO:0022027) | 2.15123958 |
| 177 | synapse assembly (GO:0007416) | 2.15020192 |
| 178 | modulation by symbiont of host cellular process (GO:0044068) | 2.14975057 |
| 179 | lipid translocation (GO:0034204) | 2.14832470 |
| 180 | B cell proliferation (GO:0042100) | 2.14519280 |
| 181 | regulation of cellular amide metabolic process (GO:0034248) | 2.13974828 |
| 182 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.12892197 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.12558753 |
| 184 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.12152752 |
| 185 | NIK/NF-kappaB signaling (GO:0038061) | 2.11791543 |
| 186 | membrane depolarization during action potential (GO:0086010) | 2.11750631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30800583 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80056930 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.07013333 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84946943 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.71843999 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.71524721 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.65506313 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63670664 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.43308094 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37277667 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36090661 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30564746 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07000357 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06971227 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06508336 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02494497 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97810888 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94808046 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91017243 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84950704 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74985211 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74792118 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69093643 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66585140 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63473923 |
| 26 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53586175 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53399701 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52859874 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51393926 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48884675 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45536521 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41750433 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41546714 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40642562 |
| 35 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40414212 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39572858 |
| 37 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37435480 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36988408 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35709769 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35709769 |
| 41 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35578362 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35493506 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35016278 |
| 44 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34996887 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33576311 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33320119 |
| 47 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32648137 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30990119 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30426309 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30381905 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30003898 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28857936 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27804390 |
| 54 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27190153 |
| 55 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27112816 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26577432 |
| 57 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24701010 |
| 58 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24617514 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23831682 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22716624 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20138928 |
| 62 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19624925 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19390846 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18890457 |
| 65 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18540922 |
| 66 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17509536 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17279126 |
| 68 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17228404 |
| 69 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16686682 |
| 70 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16637910 |
| 71 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16208919 |
| 72 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16085481 |
| 73 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15097677 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14977318 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14977318 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14785663 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14742211 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14633767 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14010633 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13867159 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.13696997 |
| 82 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.13319895 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13039705 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13039705 |
| 85 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12512751 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12313732 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11777873 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11696743 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10859587 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09647248 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09178480 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09016585 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08550304 |
| 94 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08314936 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08285595 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08152346 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07861860 |
| 98 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07831507 |
| 99 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07636216 |
| 100 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.07447280 |
| 101 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06997534 |
| 102 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06528013 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06462526 |
| 104 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05624310 |
| 105 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05073854 |
| 106 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.05060071 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03969137 |
| 108 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03419560 |
| 109 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02877684 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02649648 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02511915 |
| 112 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00799906 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99911462 |
| 114 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98876479 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94448876 |
| 116 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93520526 |
| 117 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93520526 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93155199 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92409584 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92267284 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90357937 |
| 122 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89932266 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89737249 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89700195 |
| 125 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89492575 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88905157 |
| 127 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88845257 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88530324 |
| 129 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88418869 |
| 130 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87296078 |
| 131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86558108 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86041371 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85715235 |
| 134 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85619177 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84883324 |
| 136 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.84691588 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83722265 |
| 138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83687073 |
| 139 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.83386690 |
| 140 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.82416201 |
| 141 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.82265284 |
| 142 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.81637112 |
| 143 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81444943 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81385302 |
| 145 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81214982 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81006713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.90665263 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.87580427 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.08109291 |
| 4 | MP0004510_myositis | 2.98116334 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.90079532 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.46628395 |
| 7 | MP0003303_peritoneal_inflammation | 2.46053512 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.42576715 |
| 9 | MP0005387_immune_system_phenotype | 2.39719945 |
| 10 | MP0001790_abnormal_immune_system | 2.39719945 |
| 11 | MP0003646_muscle_fatigue | 2.36275325 |
| 12 | MP0009046_muscle_twitch | 2.27648026 |
| 13 | MP0002419_abnormal_innate_immunity | 2.25828685 |
| 14 | MP0003195_calcinosis | 2.24809584 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.17862082 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.17766273 |
| 17 | MP0001800_abnormal_humoral_immune | 2.14848147 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.14016995 |
| 19 | MP0005174_abnormal_tail_pigmentation | 2.11296232 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.10115341 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.09104638 |
| 22 | MP0008260_abnormal_autophagy | 1.87327672 |
| 23 | MP0002723_abnormal_immune_serum | 1.85877534 |
| 24 | MP0004270_analgesia | 1.85789555 |
| 25 | MP0006082_CNS_inflammation | 1.85107963 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.84972020 |
| 27 | MP0003436_decreased_susceptibility_to | 1.81697886 |
| 28 | MP0005310_abnormal_salivary_gland | 1.81605708 |
| 29 | MP0005671_abnormal_response_to | 1.75093705 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.74680943 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.74589740 |
| 32 | MP0001819_abnormal_immune_cell | 1.71678320 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.70894018 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.70406694 |
| 35 | MP0002736_abnormal_nociception_after | 1.70403945 |
| 36 | MP0004885_abnormal_endolymph | 1.70316697 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.69344378 |
| 38 | MP0003880_abnormal_central_pattern | 1.68587314 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.68424967 |
| 40 | MP0009785_altered_susceptibility_to | 1.67878726 |
| 41 | MP0002064_seizures | 1.65240710 |
| 42 | MP0005025_abnormal_response_to | 1.63328754 |
| 43 | MP0004858_abnormal_nervous_system | 1.62089380 |
| 44 | MP0003690_abnormal_glial_cell | 1.58296174 |
| 45 | MP0002822_catalepsy | 1.55836309 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.52964843 |
| 47 | MP0000685_abnormal_immune_system | 1.51024097 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.46814485 |
| 49 | MP0009745_abnormal_behavioral_response | 1.46081917 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.45005405 |
| 51 | MP0004130_abnormal_muscle_cell | 1.43701056 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.39442153 |
| 53 | MP0003879_abnormal_hair_cell | 1.38689149 |
| 54 | MP0003011_delayed_dark_adaptation | 1.38373818 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.35031431 |
| 56 | MP0000778_abnormal_nervous_system | 1.34282505 |
| 57 | MP0004142_abnormal_muscle_tone | 1.33087646 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.32815939 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.29476346 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.26180764 |
| 61 | MP0003122_maternal_imprinting | 1.25904166 |
| 62 | MP0009278_abnormal_bone_marrow | 1.25645919 |
| 63 | MP0002006_tumorigenesis | 1.25471951 |
| 64 | MP0002734_abnormal_mechanical_nocicepti | 1.24981873 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.22822532 |
| 66 | MP0003045_fibrosis | 1.22484234 |
| 67 | MP0003329_amyloid_beta_deposits | 1.22299448 |
| 68 | MP0003075_altered_response_to | 1.21599616 |
| 69 | MP0005253_abnormal_eye_physiology | 1.21093337 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.20575987 |
| 71 | MP0001970_abnormal_pain_threshold | 1.20179553 |
| 72 | MP0004947_skin_inflammation | 1.18872629 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.17604475 |
| 74 | MP0003632_abnormal_nervous_system | 1.17337251 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.16659260 |
| 76 | MP0000716_abnormal_immune_system | 1.13954509 |
| 77 | MP0000604_amyloidosis | 1.13598432 |
| 78 | MP0005423_abnormal_somatic_nervous | 1.13427277 |
| 79 | MP0000371_diluted_coat_color | 1.08355683 |
| 80 | MP0000955_abnormal_spinal_cord | 1.07443620 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.06516754 |
| 82 | MP0002398_abnormal_bone_marrow | 1.05854611 |
| 83 | MP0001486_abnormal_startle_reflex | 1.04904459 |
| 84 | MP0003300_gastrointestinal_ulcer | 1.04413873 |
| 85 | MP0002405_respiratory_system_inflammati | 1.02839324 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.02270113 |
| 87 | MP0002272_abnormal_nervous_system | 1.01871838 |
| 88 | MP0002882_abnormal_neuron_morphology | 1.01329830 |
| 89 | MP0004484_altered_response_of | 1.01206927 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.01186995 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.99798198 |
| 92 | MP0002090_abnormal_vision | 0.99570155 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.98472441 |
| 94 | MP0003634_abnormal_glial_cell | 0.98283433 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.98085676 |
| 96 | MP0008569_lethality_at_weaning | 0.95734554 |
| 97 | MP0005171_absent_coat_pigmentation | 0.94906856 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.94758257 |
| 99 | MP0004811_abnormal_neuron_physiology | 0.93822559 |
| 100 | MP0003633_abnormal_nervous_system | 0.93342110 |
| 101 | MP0000920_abnormal_myelination | 0.91687739 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.91684228 |
| 103 | MP0003091_abnormal_cell_migration | 0.90195353 |
| 104 | MP0003787_abnormal_imprinting | 0.89608141 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.89175267 |
| 106 | MP0002009_preneoplasia | 0.86354139 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.86180362 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.86038937 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 0.85113253 |
| 110 | MP0005166_decreased_susceptibility_to | 0.84432153 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.84078679 |
| 112 | MP0003448_altered_tumor_morphology | 0.83382900 |
| 113 | MP0002229_neurodegeneration | 0.83053513 |
| 114 | MP0004742_abnormal_vestibular_system | 0.82154368 |
| 115 | MP0001905_abnormal_dopamine_level | 0.82006244 |
| 116 | MP0005448_abnormal_energy_balance | 0.81946136 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.80918038 |
| 118 | MP0001177_atelectasis | 0.80393736 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.80203444 |
| 120 | MP0003631_nervous_system_phenotype | 0.79746461 |
| 121 | MP0009764_decreased_sensitivity_to | 0.79153737 |
| 122 | MP0002184_abnormal_innervation | 0.78754381 |
| 123 | MP0002429_abnormal_blood_cell | 0.77077467 |
| 124 | MP0001984_abnormal_olfaction | 0.76309860 |
| 125 | MP0001851_eye_inflammation | 0.75912690 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.74035352 |
| 127 | MP0008057_abnormal_DNA_replication | 0.73955523 |
| 128 | MP0005551_abnormal_eye_electrophysiolog | 0.73472560 |
| 129 | MP0001873_stomach_inflammation | 0.73408431 |
| 130 | MP0008872_abnormal_physiological_respon | 0.73177849 |
| 131 | MP0005409_darkened_coat_color | 0.73163326 |
| 132 | MP0005535_abnormal_body_temperature | 0.72554346 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.71939096 |
| 134 | MP0005187_abnormal_penis_morphology | 0.71440708 |
| 135 | MP0003828_pulmonary_edema | 0.69849070 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.69456336 |
| 137 | MP0003724_increased_susceptibility_to | 0.68600857 |
| 138 | MP0005257_abnormal_intraocular_pressure | 0.66920786 |
| 139 | MP0008004_abnormal_stomach_pH | 0.66649917 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.66366856 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.65436467 |
| 142 | MP0004085_abnormal_heartbeat | 0.65263433 |
| 143 | MP0005386_behavior/neurological_phenoty | 0.65085197 |
| 144 | MP0004924_abnormal_behavior | 0.65085197 |
| 145 | MP0002971_abnormal_brown_adipose | 0.64824587 |
| 146 | MP0002277_abnormal_respiratory_mucosa | 0.64790728 |
| 147 | MP0002102_abnormal_ear_morphology | 0.64041592 |
| 148 | MP0004036_abnormal_muscle_relaxation | 0.62853589 |
| 149 | MP0002152_abnormal_brain_morphology | 0.62402171 |
| 150 | MP0004043_abnormal_pH_regulation | 0.61353008 |
| 151 | MP0002069_abnormal_eating/drinking_beha | 0.59986613 |
| 152 | MP0010329_abnormal_lipoprotein_level | 0.57775128 |
| 153 | MP0002752_abnormal_somatic_nervous | 0.57346209 |
| 154 | MP0002078_abnormal_glucose_homeostasis | 0.56985821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.90680963 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.28252326 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.32950084 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.30231512 |
| 5 | Hyperventilation (HP:0002883) | 4.24826179 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.00225477 |
| 7 | Febrile seizures (HP:0002373) | 3.54700990 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47563448 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47563448 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47563448 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.42627290 |
| 12 | Gingivitis (HP:0000230) | 3.24427898 |
| 13 | Focal motor seizures (HP:0011153) | 3.20308112 |
| 14 | Stomatitis (HP:0010280) | 3.15540257 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.11728150 |
| 16 | Focal seizures (HP:0007359) | 3.09382502 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02076173 |
| 18 | Hemiplegia (HP:0002301) | 2.97409521 |
| 19 | Recurrent skin infections (HP:0001581) | 2.92725280 |
| 20 | Prostate neoplasm (HP:0100787) | 2.86424518 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.81981887 |
| 22 | Broad-based gait (HP:0002136) | 2.79682972 |
| 23 | Epileptiform EEG discharges (HP:0011182) | 2.68586975 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.67793012 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.66940015 |
| 26 | Optic neuritis (HP:0100653) | 2.65836470 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.65836470 |
| 28 | Hemiparesis (HP:0001269) | 2.63875610 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63150786 |
| 30 | Obstructive lung disease (HP:0006536) | 2.63150786 |
| 31 | Amyotrophic lateral sclerosis (HP:0007354) | 2.62299851 |
| 32 | Loss of speech (HP:0002371) | 2.61942107 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.59254085 |
| 34 | Vasculitis (HP:0002633) | 2.59030863 |
| 35 | Absent frontal sinuses (HP:0002688) | 2.52379972 |
| 36 | Pheochromocytoma (HP:0002666) | 2.52063453 |
| 37 | Periodontitis (HP:0000704) | 2.51008885 |
| 38 | Submucous cleft hard palate (HP:0000176) | 2.49562193 |
| 39 | Pancreatic cysts (HP:0001737) | 2.49146313 |
| 40 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49127593 |
| 41 | Protruding tongue (HP:0010808) | 2.47570348 |
| 42 | Colitis (HP:0002583) | 2.46337235 |
| 43 | Polyphagia (HP:0002591) | 2.41678722 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.40997431 |
| 45 | Myokymia (HP:0002411) | 2.39434032 |
| 46 | Papilledema (HP:0001085) | 2.39253172 |
| 47 | Hypsarrhythmia (HP:0002521) | 2.39152049 |
| 48 | Atonic seizures (HP:0010819) | 2.36415328 |
| 49 | Dyskinesia (HP:0100660) | 2.35938170 |
| 50 | Disinhibition (HP:0000734) | 2.35782525 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35177408 |
| 52 | Mutism (HP:0002300) | 2.34759344 |
| 53 | Ulnar claw (HP:0001178) | 2.33745029 |
| 54 | Hematochezia (HP:0002573) | 2.33257644 |
| 55 | Inability to walk (HP:0002540) | 2.32504806 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.31837149 |
| 57 | Polydipsia (HP:0001959) | 2.31689554 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.31689554 |
| 59 | Cellulitis (HP:0100658) | 2.28347200 |
| 60 | Increased density of long bones (HP:0006392) | 2.26900963 |
| 61 | Action tremor (HP:0002345) | 2.25731398 |
| 62 | Progressive visual loss (HP:0000529) | 2.24206721 |
| 63 | Fair hair (HP:0002286) | 2.22530137 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.21859732 |
| 65 | Inappropriate behavior (HP:0000719) | 2.21083265 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.21015657 |
| 67 | Orchitis (HP:0100796) | 2.20934502 |
| 68 | Limb dystonia (HP:0002451) | 2.19403250 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19224506 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19224506 |
| 71 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19024478 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.18766647 |
| 73 | Myositis (HP:0100614) | 2.17485189 |
| 74 | Difficulty running (HP:0009046) | 2.16045144 |
| 75 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.15250807 |
| 76 | Generalized hypopigmentation of hair (HP:0011358) | 2.14753305 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.13776896 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.13581824 |
| 79 | Recurrent viral infections (HP:0004429) | 2.12174298 |
| 80 | Osteomyelitis (HP:0002754) | 2.11690988 |
| 81 | Axonal loss (HP:0003447) | 2.10585668 |
| 82 | Thick nail (HP:0001805) | 2.09263915 |
| 83 | Neuroendocrine neoplasm (HP:0100634) | 2.08929145 |
| 84 | Tubulointerstitial nephritis (HP:0001970) | 2.07879035 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.07037103 |
| 86 | Attenuation of retinal blood vessels (HP:0007843) | 2.06985744 |
| 87 | Abnormality of the fingertips (HP:0001211) | 2.06922121 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.04162818 |
| 89 | Oligodactyly (hands) (HP:0001180) | 2.03335829 |
| 90 | Pancreatic fibrosis (HP:0100732) | 2.02995693 |
| 91 | Abnormality of binocular vision (HP:0011514) | 2.02781255 |
| 92 | Diplopia (HP:0000651) | 2.02781255 |
| 93 | Widely spaced teeth (HP:0000687) | 2.02765828 |
| 94 | Abnormal hair whorl (HP:0010721) | 2.00794455 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00458832 |
| 96 | Agitation (HP:0000713) | 1.99861956 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 1.99751732 |
| 98 | Increased circulating renin level (HP:0000848) | 1.98281687 |
| 99 | Metabolic alkalosis (HP:0200114) | 1.98091115 |
| 100 | Ocular albinism (HP:0001107) | 1.98001323 |
| 101 | Recurrent pneumonia (HP:0006532) | 1.97174049 |
| 102 | Truncal ataxia (HP:0002078) | 1.96794718 |
| 103 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96731918 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 1.95699463 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.94974185 |
| 106 | Meningitis (HP:0001287) | 1.94312303 |
| 107 | Visual hallucinations (HP:0002367) | 1.93471139 |
| 108 | Dialeptic seizures (HP:0011146) | 1.92776643 |
| 109 | Hip dysplasia (HP:0001385) | 1.92742358 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.92538617 |
| 111 | Neuronal loss in central nervous system (HP:0002529) | 1.92207534 |
| 112 | Pulmonary infiltrates (HP:0002113) | 1.92008820 |
| 113 | Impaired smooth pursuit (HP:0007772) | 1.91747589 |
| 114 | True hermaphroditism (HP:0010459) | 1.91043770 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.90850322 |
| 116 | Restrictive lung disease (HP:0002091) | 1.90440012 |
| 117 | Abnormality of the renal medulla (HP:0100957) | 1.89560536 |
| 118 | Spastic gait (HP:0002064) | 1.88348022 |
| 119 | Generalized tonic-clonic seizures (HP:0002069) | 1.88291917 |
| 120 | Clumsiness (HP:0002312) | 1.88072661 |
| 121 | Absent speech (HP:0001344) | 1.87811582 |
| 122 | Progressive inability to walk (HP:0002505) | 1.87476825 |
| 123 | Bradykinesia (HP:0002067) | 1.87119502 |
| 124 | Interstitial pulmonary disease (HP:0006530) | 1.85843740 |
| 125 | Hypokalemic alkalosis (HP:0001949) | 1.85692814 |
| 126 | Generalized hypopigmentation (HP:0007513) | 1.84802057 |
| 127 | Prolonged QT interval (HP:0001657) | 1.84649848 |
| 128 | Impaired vibratory sensation (HP:0002495) | 1.84272704 |
| 129 | Poor eye contact (HP:0000817) | 1.83952559 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 1.83557806 |
| 131 | Chronic hepatic failure (HP:0100626) | 1.83432178 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83143641 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83143641 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83143641 |
| 135 | Syncope (HP:0001279) | 1.83036036 |
| 136 | Agnosia (HP:0010524) | 1.82962085 |
| 137 | Menstrual irregularities (HP:0000858) | 1.80711162 |
| 138 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80679040 |
| 139 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80679040 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.80647382 |
| 141 | Iris hypopigmentation (HP:0007730) | 1.80484358 |
| 142 | Truncal obesity (HP:0001956) | 1.80117509 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.79982910 |
| 144 | Progressive hearing impairment (HP:0001730) | 1.79678211 |
| 145 | Stomach cancer (HP:0012126) | 1.79120877 |
| 146 | Slow saccadic eye movements (HP:0000514) | 1.78096052 |
| 147 | Onion bulb formation (HP:0003383) | 1.77065173 |
| 148 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76948408 |
| 149 | Genetic anticipation (HP:0003743) | 1.75784609 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.75386144 |
| 151 | Congenital stationary night blindness (HP:0007642) | 1.75159853 |
| 152 | Progressive sensorineural hearing impairment (HP:0000408) | 1.74665020 |
| 153 | Absence seizures (HP:0002121) | 1.73692190 |
| 154 | Nephronophthisis (HP:0000090) | 1.73195649 |
| 155 | Papillary thyroid carcinoma (HP:0002895) | 1.72577686 |
| 156 | Postural instability (HP:0002172) | 1.72140817 |
| 157 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.71703374 |
| 158 | Excessive salivation (HP:0003781) | 1.71466888 |
| 159 | Drooling (HP:0002307) | 1.71466888 |
| 160 | Hypothermia (HP:0002045) | 1.70407975 |
| 161 | Thyroiditis (HP:0100646) | 1.67764981 |
| 162 | Congenital sensorineural hearing impairment (HP:0008527) | 1.67121303 |
| 163 | Status epilepticus (HP:0002133) | 1.65626078 |
| 164 | T lymphocytopenia (HP:0005403) | 1.65316014 |
| 165 | Gait imbalance (HP:0002141) | 1.64760375 |
| 166 | Lower limb muscle weakness (HP:0007340) | 1.64286688 |
| 167 | Increased CSF protein (HP:0002922) | 1.63700823 |
| 168 | Intention tremor (HP:0002080) | 1.63617599 |
| 169 | Abnormality of salivation (HP:0100755) | 1.63290129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.23166566 |
| 2 | FRK | 3.98818321 |
| 3 | MAP3K14 | 3.19111115 |
| 4 | MAP3K13 | 2.86830854 |
| 5 | MARK1 | 2.84929067 |
| 6 | MAP4K1 | 2.84402357 |
| 7 | IRAK3 | 2.59088049 |
| 8 | MAP3K9 | 2.50203044 |
| 9 | TYK2 | 2.28486671 |
| 10 | JAK1 | 2.19166808 |
| 11 | IRAK4 | 2.14086507 |
| 12 | PINK1 | 2.06918091 |
| 13 | NTRK3 | 2.00524162 |
| 14 | ACVR1B | 1.92716216 |
| 15 | DAPK2 | 1.90465086 |
| 16 | SIK2 | 1.86015951 |
| 17 | BMPR2 | 1.81857273 |
| 18 | FGR | 1.80864491 |
| 19 | FES | 1.80523354 |
| 20 | TAOK3 | 1.75459819 |
| 21 | IKBKE | 1.58162842 |
| 22 | KIT | 1.56502674 |
| 23 | BLK | 1.54153594 |
| 24 | ADRBK2 | 1.52338862 |
| 25 | IKBKB | 1.48969718 |
| 26 | TBK1 | 1.48803383 |
| 27 | CSF1R | 1.46435623 |
| 28 | SYK | 1.44492514 |
| 29 | PAK3 | 1.42399838 |
| 30 | SGK2 | 1.38342487 |
| 31 | CAMK1 | 1.37239899 |
| 32 | SGK3 | 1.36524403 |
| 33 | NLK | 1.31771901 |
| 34 | HCK | 1.31469980 |
| 35 | TXK | 1.29532280 |
| 36 | INSRR | 1.25700458 |
| 37 | GRK5 | 1.23227363 |
| 38 | CAMK1G | 1.21043697 |
| 39 | GRK7 | 1.17114056 |
| 40 | EPHA4 | 1.16704026 |
| 41 | PRPF4B | 1.14826044 |
| 42 | CAMKK1 | 1.10408982 |
| 43 | GRK1 | 1.10159665 |
| 44 | NEK6 | 1.09821684 |
| 45 | CAMK4 | 1.09212010 |
| 46 | MAP2K4 | 1.07087372 |
| 47 | CDK12 | 1.06280985 |
| 48 | NEK9 | 1.04750892 |
| 49 | MINK1 | 1.03984085 |
| 50 | PRKCH | 1.03802920 |
| 51 | TNIK | 1.01903678 |
| 52 | WNK3 | 1.00766109 |
| 53 | CAMKK2 | 0.99478110 |
| 54 | CHUK | 0.98785228 |
| 55 | MARK3 | 0.97909372 |
| 56 | CAMK1D | 0.97413572 |
| 57 | PAK6 | 0.95795114 |
| 58 | PRKCG | 0.95744078 |
| 59 | PLK2 | 0.93658888 |
| 60 | SGK494 | 0.92957377 |
| 61 | SGK223 | 0.92957377 |
| 62 | PDK1 | 0.90894814 |
| 63 | KSR2 | 0.90797268 |
| 64 | DYRK1A | 0.90009433 |
| 65 | NTRK1 | 0.89602304 |
| 66 | JAK3 | 0.88927408 |
| 67 | AKT3 | 0.87381166 |
| 68 | PHKG1 | 0.87364102 |
| 69 | PHKG2 | 0.87364102 |
| 70 | BRD4 | 0.85469077 |
| 71 | LYN | 0.85322295 |
| 72 | PNCK | 0.85212800 |
| 73 | MARK2 | 0.85142234 |
| 74 | MATK | 0.84872584 |
| 75 | SGK1 | 0.84393830 |
| 76 | UHMK1 | 0.84000605 |
| 77 | WNK1 | 0.83667520 |
| 78 | CSK | 0.82288770 |
| 79 | OXSR1 | 0.79993309 |
| 80 | CDK5 | 0.77273639 |
| 81 | PIK3CG | 0.75853265 |
| 82 | MAP3K2 | 0.74802284 |
| 83 | LCK | 0.74475798 |
| 84 | MAP3K7 | 0.72884610 |
| 85 | SIK3 | 0.71537538 |
| 86 | CDK3 | 0.71515667 |
| 87 | PIK3CA | 0.71167562 |
| 88 | CAMK2A | 0.69888542 |
| 89 | YES1 | 0.69517986 |
| 90 | MAP2K7 | 0.68976500 |
| 91 | STK38 | 0.68539823 |
| 92 | CSNK1G2 | 0.68502371 |
| 93 | HIPK2 | 0.68285125 |
| 94 | PRKCQ | 0.66554066 |
| 95 | TGFBR2 | 0.64428222 |
| 96 | PDPK1 | 0.64194507 |
| 97 | ARAF | 0.63893746 |
| 98 | STK24 | 0.63070230 |
| 99 | DAPK1 | 0.62748721 |
| 100 | FYN | 0.62012385 |
| 101 | MAPK7 | 0.62009138 |
| 102 | MAP3K4 | 0.61969257 |
| 103 | FGFR2 | 0.61417500 |
| 104 | PKN1 | 0.61288340 |
| 105 | OBSCN | 0.61099779 |
| 106 | ADRBK1 | 0.60597172 |
| 107 | TYRO3 | 0.60040952 |
| 108 | JAK2 | 0.59572537 |
| 109 | FGFR3 | 0.59434854 |
| 110 | MAP2K6 | 0.59349465 |
| 111 | BMPR1B | 0.59062361 |
| 112 | CASK | 0.58567036 |
| 113 | MAPK13 | 0.58127003 |
| 114 | PRKCZ | 0.57488637 |
| 115 | PRKAA2 | 0.57250626 |
| 116 | MAPK10 | 0.56958159 |
| 117 | RPS6KA2 | 0.56119205 |
| 118 | STK11 | 0.55361789 |
| 119 | NTRK2 | 0.53413288 |
| 120 | PRKCE | 0.52690721 |
| 121 | RET | 0.52076968 |
| 122 | ERBB2 | 0.50091180 |
| 123 | PRKAA1 | 0.49969644 |
| 124 | FER | 0.49173467 |
| 125 | PRKG1 | 0.48167848 |
| 126 | MAP4K2 | 0.47893365 |
| 127 | MAP3K12 | 0.46911685 |
| 128 | CSNK1G1 | 0.46232163 |
| 129 | EPHA3 | 0.45566435 |
| 130 | RPS6KA3 | 0.45445467 |
| 131 | EGFR | 0.45021400 |
| 132 | CAMK2B | 0.44354942 |
| 133 | ALK | 0.44093481 |
| 134 | MAPKAPK5 | 0.43402423 |
| 135 | PRKCD | 0.42472190 |
| 136 | TNK2 | 0.42393052 |
| 137 | EPHB1 | 0.40128812 |
| 138 | ABL1 | 0.38846043 |
| 139 | ZAP70 | 0.34283069 |
| 140 | PTK2B | 0.34217266 |
| 141 | MOS | 0.31409750 |
| 142 | IRAK2 | 0.31184574 |
| 143 | MAPK12 | 0.30990456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99196035 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86168426 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84934532 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.78826654 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64515061 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.63766817 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 1.63532991 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 1.62213385 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54494221 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51589322 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.51450007 |
| 12 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.49582666 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.47314469 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43898172 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40294781 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.38452621 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36447815 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32457613 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31747851 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30648582 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30284493 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28675925 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27239183 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.24339990 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23162799 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.19079975 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17981747 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17628803 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15841392 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15672461 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15157302 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14450392 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14364824 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12942385 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09917281 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.09788809 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09390992 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09216274 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.09101486 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.08833464 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08647379 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08555822 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.08306145 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05834892 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05737758 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.04957360 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04366439 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04093650 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03914183 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03782532 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01550460 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99555252 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98649204 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98352303 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97435521 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97051576 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96910526 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96715611 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95921444 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95571455 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94993074 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.94633513 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94560449 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92907714 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91553273 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.91079395 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89235965 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88951301 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.88792569 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88770478 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88691047 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87198651 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86523675 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.85713498 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84671275 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84499253 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.83689649 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83042711 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82544435 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81996527 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81501915 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81473360 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.81224313 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81172586 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.78857646 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.78757855 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78641271 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78433881 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.76698788 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.75791728 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.75443793 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75054375 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74988841 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.74870436 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.74808733 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74371690 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73004065 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72843743 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72274313 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72083041 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71657791 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70336027 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70137736 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68932260 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68636346 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68329781 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67389651 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66995887 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66324574 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.65889737 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64911496 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64666463 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64246534 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64107851 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63719880 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63700425 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63446777 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63283540 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62937360 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62882746 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62596272 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62303369 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62191984 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61222826 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.59170200 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.58858035 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55778965 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51653664 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50069040 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48123238 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46744066 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46518670 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45391862 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.44508338 |
| 135 | Axon guidance_Homo sapiens_hsa04360 | 0.43795987 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.43251756 |
| 137 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41285409 |

